The Quarter 1, 2022 billing codes for drugs and biologics and MedTech have been posted. However, being assigned a code[…]
Read more
Category: Future Trends
As Two Proposed Bills are Considered for Telehealth, How Could it Impact your Products?
In the past year, the pandemic has changed the nature of how we operate in our day-to-day lives. Among them,[…]
Read more
As CMS Updates its Hospital Outpatient Prior Authorization List for 2021, are Your Accounts Educated About the 2021 Changes?
In June 2020, the Centers for Medicare and Medicaid Services (CMS) implemented a prior authorization (PA) program for certain hospital outpatient[…]
Read more
Federally Funded Health Centers Gain $1 Billion in Funding, Are You Aware of Their Importance in Improving Access to Your Products and Improving Patient Compliance?
Following the latest in reimbursement news, we recently covered the $80 million in funding for Navigators in Federal Marketplaces for[…]
Read more
Are You Strategizing for Market Access Given Centene’s Medicaid Expansion Trends?
Centene Corporation (Centene) is an important payer for our clients, and we have tracked the trends with this payer to[…]
Read more
Perform these Five Key Steps to Assess if the Clinical Outcome Strategies of Your Company Supports Market Access?
The medical policy teams of insurers in the U.S. are busy in the first two quarters of the year conducting[…]
Read more
Contemplate Both Traditional Medicare & Medicare Advantage for your MedTech Medicare Strategies!
In 2020, GIRS spotlighted upcoming Medicare Advantage (MA) growth for 2021. In our recent updates, GIRS continues to track payer growth, specifically[…]
Read more
Arkansas is Poised for Medicaid Managed Care Expansion in 2022? How will this Impact Market Access for your Product?
For over 19 years, GIRS has tracked payer trends to develop and implement market access strategies for our clients’ Products. […]
Read more
What is the Impact of the Federal Marketplace Expansion for your Medtech Products?
GIRS has been tracking payer trends for the past 19 years to assist with the market uptake of client Products.[…]
Read more
#Medtech Reimbursement Changes 2021: Medicare Advantage (MA) Changes for Beneficiaries with End-Stage Renal Disease (ESRD)
What does the future hold for #Medtech? Take a look at our short video with details regarding Medicare Advantage changes[…]
Read more